Pathology Services in Australia - Industry Risk Rating Report
INDUSTRY RISK RATINGS REPORT
This is the replacement for July 2009 edition of Pathology Services in Australia Industry Risk Ratings Report.
Industry Risk Ratings Synopsis
This Industry Risk Ratings report evaluates the inherent risks associated with the Pathology Services in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'.
The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected future performance of the industry (growth risk) and risk arising from forces external to the industry (external sensitivity risk).
This approach is new in that it analyses non-financial information surrounding each industry. Industries are scored on a 9-point scale, where 1 represents the lowest risk and 9 the highest. The Industry Risk score measures expected Industry Risk over the coming 12-18 months.
Industry Definition
Report Contents
Risk Overview
The Risk Overview chapter includes sections on Industry Definition and Activities, Industry Risk Score and Risk Rating Analysis. The Industry Definition and Activities section provides a detailed definition of the activities carried out by operators in this industry as defined in NAICS. A list of the primary activities of the industry is also included. The Industry Risk Score section provides the Overall Industry Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Industry Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Industry Risk Score.
Structural Risk
The Structural Risk chapter looks at risk arising from within the industry itself and provides a detailed discussion of the industry’s level of exposure to seven key indicators. These key indicators are Barriers to Entry, Competition, Industry Exports, Industry Imports, Level of Assistance, Life Cycle Stage and Volatility of Industry. The Overall Structural Risk Score is a weighted aggregation of these seven key indicators. Each of the key indicators is discussed in detail in this section.
Growth Risk
The Growth Risk chapter looks at risks arising from the expected future performance of the industry. The Overall Growth Risk Score is determined by amalgamating the scores for Recent Industry Growth and Forecast Industry Growth. Detailed analysis is provided discussing the reasons for the growth scores of both.
Sensitivity Risk
The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the industry. The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the industry. Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a detailed analysis of the affect each of the sensitivities has on the industry, including charts and data tables where appropriate.
Industry Risk and Industry Risk Scoring Methodology
This chapter provides an overview of how the author defines Industry Risk and discusses the methodology used to arrive at an Industry Risk Score. There is also a table that provides a definition of the seven levels of Industry Risk.
O8631 - Pathology Services in Australia
RELATED REPORTS
The Asthma Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, an overview of short-acting medications for quick relief of symptoms, and a review of treatments used to provide long-term control. Dosing information and treatment costs ...
The Major Depressive Disorder Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments, including SSRIs and atypical antidepressants, tricyclic antidepressants, monoamine oxidase inhibi ...
The Prostate Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatments for localized disease, locally and regionally advanced disease, and metastatic disease. Dosing ...
The Insomnia Disease and Therapy Review provides prevalence numbers and percentages for major countries worldwide, information on diagnostic criteria, and an overview of treatments. Dosing information and treatment costs are provided for Rozerem, Sonata, Lunesta, and Ambien. General information i ...
The Bipolar Disorder Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments including mood stabilizers, antidepressants, antipsychotics, and anticonvulsants. Dosing information and ...
Clinical guidelines for the evaluation and management of these 2 common disorders with extensive references and resources ...
Industries : Pathology
The diagnosis, evaluation and management (non-pharmaceutical and pharmaceutical) of this common cluster (includes PTSD and OCD guidelines) of disabling disorders are supported by references, web links, screening tools, other resources ...
Industries : Pathology
Related industries
reportlinker.com © Copyright 2009. All rights reserved